152 related articles for article (PubMed ID: 16523184)
1. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability of the fructosamine 3-kinase gene in diabetic patients.
Mosca L; Penco S; Patrosso MC; Marocchi A; Lapolla A; Sartore G; Chilelli NC; Paleari R; Mosca A
Clin Chem Lab Med; 2011 May; 49(5):803-8. PubMed ID: 21288167
[TBL] [Abstract][Full Text] [Related]
3. Increased protein glycation in fructosamine 3-kinase-deficient mice.
Veiga da-Cunha M; Jacquemin P; Delpierre G; Godfraind C; Théate I; Vertommen D; Clotman F; Lemaigre F; Devuyst O; Van Schaftingen E
Biochem J; 2006 Oct; 399(2):257-64. PubMed ID: 16819943
[TBL] [Abstract][Full Text] [Related]
4. A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes.
Hellwig A; Scherber A; Koehler C; Hanefeld M; Henle T
Clin Chem Lab Med; 2014 Jan; 52(1):93-101. PubMed ID: 23648633
[TBL] [Abstract][Full Text] [Related]
5. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.
Delpierrre G; Vertommen D; Communi D; Rider MH; Van Schaftingen E
J Biol Chem; 2004 Jun; 279(26):27613-20. PubMed ID: 15102834
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic deglycation--a new paradigm or an epiphenomenon?
Szwergold BS; Beisswenger PJ
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1428-32. PubMed ID: 14641081
[TBL] [Abstract][Full Text] [Related]
7. Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.
Sartore G; Ragazzi E; Burlina S; Paleari R; Chilelli NC; Mosca A; Avemaria F; Lapolla A
BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32467223
[TBL] [Abstract][Full Text] [Related]
8. Fructosamine 3-kinase-related protein and deglycation in human erythrocytes.
Collard F; Wiame E; Bergans N; Fortpied J; Vertommen D; Vanstapel F; Delpierre G; Van Schaftingen E
Biochem J; 2004 Aug; 382(Pt 1):137-43. PubMed ID: 15137908
[TBL] [Abstract][Full Text] [Related]
9. A simple colorimetric assay for measuring fructosamine 3 kinase activity.
Cikomola JC; Kishabongo AS; Vandepoele K; Mulder M; Katchunga PB; Laukens B; Schie LV; Grootaert H; Callewaert N; Speeckaert MM; Delanghe JR
Clin Chem Lab Med; 2017 Jan; 55(1):154-159. PubMed ID: 27394048
[TBL] [Abstract][Full Text] [Related]
10. Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes.
Dunmore SJ; Al-Derawi AS; Nayak AU; Narshi A; Nevill AM; Hellwig A; Majebi A; Kirkham P; Brown JE; Singh BM
Diabetes; 2018 Jan; 67(1):131-136. PubMed ID: 29066600
[TBL] [Abstract][Full Text] [Related]
11. A convenient HPLC assay for the determination of fructosamine-3-kinase activity in erythrocytes.
Krause R; Oehme A; Wolf K; Henle T
Anal Bioanal Chem; 2006 Dec; 386(7-8):2019-25. PubMed ID: 17072594
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c Levels and the onset of type 2 diabetes mellitus.
Mohás M; Kisfali P; Baricza E; Mérei A; Maász A; Cseh J; Mikolás E; Szijártó IA; Melegh B; Wittmann I
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):209-12. PubMed ID: 19834870
[TBL] [Abstract][Full Text] [Related]
13. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
[TBL] [Abstract][Full Text] [Related]
14. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
Szwergold BS; Howell S; Beisswenger PJ
Diabetes; 2001 Sep; 50(9):2139-47. PubMed ID: 11522682
[TBL] [Abstract][Full Text] [Related]
15. Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.
Avemaria F; Carrera P; Lapolla A; Sartore G; Chilelli NC; Paleari R; Ambrosi A; Ferrari M; Mosca A
Clin Chem Lab Med; 2015 Aug; 53(9):1315-20. PubMed ID: 26352355
[TBL] [Abstract][Full Text] [Related]
16. Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes.
Delpierre G; Collard F; Fortpied J; Van Schaftingen E
Biochem J; 2002 Aug; 365(Pt 3):801-8. PubMed ID: 11975663
[TBL] [Abstract][Full Text] [Related]
17. Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes.
Škrha J; Muravská A; Flekač M; Horová E; Novák J; Novotný A; Prázný M; Škrha J; Kvasnička J; Landová L; Jáchymová M; Zima T; Kalousová M
Physiol Res; 2014; 63(Suppl 2):S283-91. PubMed ID: 24908234
[TBL] [Abstract][Full Text] [Related]
18. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
Conner JR; Beisswenger PJ; Szwergold BS
Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.
Delplanque J; Delpierre G; Opperdoes FR; Van Schaftingen E
J Biol Chem; 2004 Nov; 279(45):46606-13. PubMed ID: 15331600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
